Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Joachim G J V, Aerts"'
Autor:
Julia C. Berentschot, Willemijn A. de Ridder, L. Martine Bek, Majanka H. Heijenbrok-Kal, Gert-Jan Braunstahl, Sylvia C. Remerie, Yvonne Stuip, Gerard M. Ribbers, Joachim G. J. V. Aerts, Erwin Ista, Merel E. Hellemons, Rita J. G. van den Berg-Emons, the CO-FLOW Collaboration Group
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Background Patient experiences with COVID-19 aftercare remain largely unknown. We evaluated COVID-19 aftercare from a patient perspective one year after hospitalization, assessing satisfaction and its associated factors, and unmet needs. Met
Externí odkaz:
https://doaj.org/article/ed212dcd462b4b5e9a2f551dc115067d
Autor:
Julia C. Berentschot, Hemmo A. Drexhage, Daniel G. Aynekulu Mersha, Annemarie J. M. Wijkhuijs, Corine H. GeurtsvanKessel, Marion P. G. Koopmans, Jolanda J. C. Voermans, Rudi W. Hendriks, Nicole M. A. Nagtzaam, Maaike de Bie, Majanka H. Heijenbrok-Kal, L. Martine Bek, Gerard M. Ribbers, Rita J. G. van den Berg-Emons, Joachim G. J. V. Aerts, Willem A. Dik, Merel E. Hellemons
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundMany patients with SARS-CoV-2 infection develop long COVID with fatigue as one of the most disabling symptoms. We performed clinical and immune profiling of fatigued and non-fatigued long COVID patients and age- and sex-matched healthy cont
Externí odkaz:
https://doaj.org/article/e0596feea1eb4a5281d08dc5597ad25c
Autor:
Nadine L de Boer, Job P van Kooten, Cornelis Verhoef, Joachim G J V Aerts, Eva V E Madsen, Alexandra R M Brandt-Kerkhof, Marcella Willemsen, Michelle V Dietz, Katrien L A Quintelier, Madelief Vink, Yvan Saeys, Sofie Van Gassen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Background Malignant peritoneal mesothelioma (MPM) is an aggressive malignancy with a poor prognosis. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) improves survival outcomes, but recurrence rates remain high. Dend
Externí odkaz:
https://doaj.org/article/4969d9c96188451cb2fee28a466fa4a5
Autor:
Giuseppe L. Banna, Marcello Tiseo, Diego L. Cortinovis, Francesco Facchinetti, Joachim G. J. V. Aerts, Cinzia Baldessari, Raffaele Giusti, Emilio Bria, Francesco Grossi, Rossana Berardi, Alessandro Morabito, Annamaria Catino, Carlo Genova, Francesca Mazzoni, Alain Gelibter, Francesca Rastelli, Marianna Macerelli, Rita Chiari, Stefania Gori, Giovanni Mansueto, Fabrizio Citarella, Luca Cantini, Erika Rijavec, Federica Bertolini, Federico Cappuzzo, Alessandro De Toma, Alex Friedlaender, Giulio Metro, Maria Vittoria Pensieri, Giampiero Porzio, Corrado Ficorella, David J. Pinato, Alessio Cortellini, Alfredo Addeo
Publikováno v:
Thoracic Cancer, Vol 13, Iss 3, Pp 483-488 (2022)
Abstract Background Patients with programmed cell death‐ligand 1 (PD‐L1) ≥50% metastatic non‐small cell lung cancer (mNSCLC) and ECOG performance status (PS) of 2 treated with first‐line immunotherapy have heterogeneous clinical assessment
Externí odkaz:
https://doaj.org/article/c6c73bc779d045abbf30461995e450e6
Autor:
Alessio Cortellini, Raffaele Giusti, Marco Filetti, Fabrizio Citarella, Vincenzo Adamo, Daniele Santini, Sebastiano Buti, Olga Nigro, Luca Cantini, Massimo Di Maio, Joachim G. J. V. Aerts, Emilio Bria, Federica Bertolini, Miriam Grazia Ferrara, Michele Ghidini, Francesco Grossi, Annalisa Guida, Rossana Berardi, Alessandro Morabito, Carlo Genova, Francesca Mazzoni, Lorenzo Antonuzzo, Alain Gelibter, Paolo Marchetti, Rita Chiari, Marianna Macerelli, Francesca Rastelli, Luigi Della Gravara, Stefania Gori, Alessandro Tuzi, Michele De Tursi, Pietro Di Marino, Giovanni Mansueto, Federica Pecci, Federica Zoratto, Serena Ricciardi, Maria Rita Migliorino, Francesco Passiglia, Giulio Metro, Gian Paolo Spinelli, Giuseppe L. Banna, Alex Friedlaender, Alfredo Addeo, Corrado Ficorella, Giampiero Porzio, Marcello Tiseo, Marco Russano, Alessandro Russo, David James Pinato
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-6 (2022)
Abstract Family history of cancer (FHC) is a hallmark of cancer risk and an independent predictor of outcome, albeit with uncertain biologic foundations. We previously showed that FHC-high patients experienced prolonged overall (OS) and progression-f
Externí odkaz:
https://doaj.org/article/ef36c449c9224564a2852f68941a9276
Autor:
L. Martine Bek, Julia C. Berentschot, Merel E. Hellemons, Susanne M. Huijts, Joachim G. J. V. Aerts, Jasper van Bommel, Michel E. van Genderen, Diederik A. M. P. J. Gommers, Gerard M. Ribbers, Majanka H. Heijenbrok-Kal, Rita J. G. van den Berg-Emons, the CO-FLOW Collaboration Group
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background First studies indicate that up to 6 months after hospital discharge, coronavirus disease 2019 (COVID-19) causes severe physical, cognitive, and psychological impairments, which may affect participation and health-related quality o
Externí odkaz:
https://doaj.org/article/91b3bbf8a01b4220bfc29bd6114316e7
Autor:
Job P van Kooten, Jacobus W A Burger, Cornelis Verhoef, Joachim G J V Aerts, Eva V E Madsen, Alexandra R M Brandt-Kerkhof, Stijn L W Koolen, Ron H J Mathijssen, Michelle V Dietz, Niels A D Guchelaar
Publikováno v:
BMJ Open, Vol 12, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/e7161b1c5eba46dd991db50fc83693eb
Autor:
Joachim G J V Aerts, Sjoerd H van der Burg, Martijn P Lolkema, Sai Ping Lau, Freek R van ’t Land, Marjolein Y V Homs, Casper H J van Eijck
Publikováno v:
BMJ Open, Vol 12, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/40029583d6574b97bc53298a9b94c429
Autor:
Daan P. Hurkmans, Edwin A. Basak, Tanja van Dijk, Darlene Mercieca, Marco W. J. Schreurs, Annemarie J. M. Wijkhuijs, Sander Bins, Esther Oomen-de Hoop, Reno Debets, Markus Joerger, Arlette Odink, Astrid A. M. van der Veldt, Cor H. van der Leest, Joachim G. J. V. Aerts, Ron H. J. Mathijssen, Stijn L. W. Koolen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)
Abstract Background Nivolumab is administered in a weight-based or fixed-flat dosing regimen. For patients with non-small cell lung cancer (NSCLC), a potential exposure-response relationship has recently been reported and may argue against the curren
Externí odkaz:
https://doaj.org/article/f8d983aed7774b85a3a382836c2bce1a
Autor:
Andre Kunert, Edwin A. Basak, Daan P. Hurkmans, Hayri E. Balcioglu, Yarne Klaver, Mandy van Brakel, Astrid A. M. Oostvogels, Cor H. J. Lamers, Sander Bins, Stijn L. W. Koolen, Astrid A. M. van der Veldt, Stefan Sleijfer, Ron H. J. Mathijssen, Joachim G. J. V. Aerts, Reno Debets
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Checkpoint inhibitors have become standard care of treatment for non-small cell lung cancer (NSCLC), yet only a limited fraction of patients experiences durable clinical benefit, highlighting the need for markers to stratify patie
Externí odkaz:
https://doaj.org/article/85ac7d6b829b414e9203975733252de9